Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001811169 | SCV001473267 | uncertain significance | not provided | 2020-08-27 | criteria provided, single submitter | clinical testing | The Hb Park Ridge variant (HBA2: c.30C>G; p.Asn10Lys, also known as Asn9Lys when numbered from the mature protein, rs111033604) is reported in the literature in the heterozygous state in a healthy individual with normal hematology (Hoyer 2002, HbVar database). However, the phenotype of this variant in the presence of other alpha globin variants is unknown. The Hb Park Ridge variant is reported in ClinVar (Variation ID: 15650), but is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database). The asparagine at residue 9 is weakly conserved, and computational algorithms (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the Asn9Lys variant is uncertain at this time. References: Link to HbVar database for Hb Park Ridge: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=914 Hoyer JD et al. Four new variants of the alpha2-globin gene without clinical or hematologic effects: Hb Park Ridge (alpha9(alpha7)Asn-->Lys (alpha2)), Hb Norton (alpha72(EF1)His-->Asp (alpha2)), Hb Lombard (alpha103(G10)His-->Tyr (alpha2)), and Hb San Antonio (A113(GH2)Leu-->Arg (A2)). Hemoglobin. 2002 May;26(2):175-9. |
OMIM | RCV000016936 | SCV000037207 | other | HEMOGLOBIN PARK RIDGE | 2013-03-28 | no assertion criteria provided | literature only | |
Natera, |
RCV001826472 | SCV002093839 | uncertain significance | alpha Thalassemia | 2021-02-16 | no assertion criteria provided | clinical testing |